ArticleTherapeutic advances in hematology2020

Co-transplantation of mesenchymal stem cells makes haploidentical HSCT a potential comparable therapy with matched sibling donor HSCT for patients with severe aplastic anemia.

Zenghui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.